E.G. Respiratuar Bozuklukların Tedavisinde Kullanım İçin Pı3k İnhibitörleri Olarak 6-(1h-İndol-4-İl)-4-(5-{[4-(1- Metiletil)-1-Piperazinil] Metil}-1,3-Oksazol-2-İl)-1h-İndazol Polimorfları Ve Tuzları.

Invention Abstract

Mevcut buluş, P13 kinaz aktivitesinin bir inhibitörü olan bir formül (II) bileşiğinin bir polimorfuna ve tuzlarına ve bunların polimorflarına yöneliktir.

IPC Classes

C07D 413/14A61P 35/00A61P 11/00A61K 31/422A61P 37/00A61P 31/12

Parties

Inventor

Julıe Nıcole Hamblın Glaxosmithkline, Gunnels Wood Road, Stevenage Hertfordshire Sg1 2ny İngiltere Paul Spencer Jones C/O Glaxosmithkline, Gunnels Wood Road, Stevenage, Hertfordshire Sg1 2ny İngiltere Robert Davıd Wıllacy Glaxosmithkline, Gunnels Wood Road, Stevenage Hertfordshire Sg1 2ny İngiltere Joelle Le Glaxosmithkline, Gunnels Wood Road, Stevenage Hertfordshire Sg1 2ny İngiltere Nıgel James Parr Glaxosmithkline, Gunnels Wood Road, Stevenage Hertfordshire Sg1 2ny İngiltere Suzanne Elaıne Keelıng C/O Glaxosmithkline, Gunnels Wood Road, Stevenage Hertfordshire Sg1 2ny İngiltere

Rights Holder

Glaxo Group Lımıted 980 Great West Road, Brentford, Middlesex Tw8 9gs İngiltere

Attorney

Nükhet Serra Coral (Deriş Patent Ve Marka Acentalığı A.Ş.) İnebolu Sok. Deriş Patent Binası No:5 Kabataş/ Setüstü 80040/İstanbul

This record is compiled from official TPMK patent bulletins and is provided for information. The abstract text is as published, in Turkish. The current legal status (opposition, assignment, invalidation) requires a full register review. Ask our experts for a comprehensive patent search.